OpenEvidence

Anthropic and medical knowledge platform OpenEvidence said on September 22, 2026 that they are collaborating to deliver AI-powered clinical decision support free to healthcare providers in low- and middle-income countries, Reuters reported exclusively. The initiative is a specialised version of OpenEvidence rolling out in about 100 countries including Uganda, Angola, Sudan, Haiti and Mongolia, per a list provided by OpenEvidence; the platform is already free to clinicians in the US and Europe. The deal pushes Claude into clinical workflows across a new set of geographies and builds Anthropic's healthcare vertical ahead of its IPO.

Source: Reuters

Sacra estimates that OpenEvidence hit $300M in annualized revenue in July 2026, up from $150M at the end of 2025.

Source: Sacra

On Sep 11, 2026 OpenEvidence and MINC#NIMC, the federally incorporated not-for-profit that issues lifetime physician identifiers in Canada (founded by the Federation of Medical Regulatory Authorities of Canada and the Medical Council of Canada), announced a partnership letting Canadian physicians verify with their MINC number for continued free access to OpenEvidence. The company said its platform is already used by more than 50% of physicians in Canada; CEO Daniel Nadler said keeping it free for Canadian doctors is personal to him. It formalizes OpenEvidence's first major international distribution channel and discloses a striking penetration metric.

Source: Unite.AI